Evonetix unveils new branding to align with its vision for gene-length DNA synthesis Post author: Post published:October 2, 2023 Post category:uncategorized EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding. You Might Also Like New cases of dementia decline while prevalence continues to increase due to population aging May 21, 2025 Cellular process discovery may lead to new cancer treatments June 12, 2026 Poor lung gas exchange may help explain lingering brain symptoms in Long COVID November 25, 2025
New cases of dementia decline while prevalence continues to increase due to population aging May 21, 2025